BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noble J, Jouve T, Malvezzi P, Süsal C, Rostaing L. Transplantation of Marginal Organs: Immunological Aspects and Therapeutic Perspectives in Kidney Transplantation. Front Immunol 2019;10:3142. [PMID: 32082306 DOI: 10.3389/fimmu.2019.03142] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Huang X, Jia Y, Zhu X, Zhang Y, Jiang L, Wei X, Zhao D, Zhao X, Du Y. Effects of Statins on Lipid Profile of Kidney Transplant Recipients: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int 2020;2020:9094543. [PMID: 32462035 DOI: 10.1155/2020/9094543] [Reference Citation Analysis]
2 Gerbase-DeLima M, de Marco R, Monteiro F, Tedesco-Silva H, Medina-Pestana JO, Mine KL. Impact of Combinations of Donor and Recipient Ages and Other Factors on Kidney Graft Outcomes. Front Immunol 2020;11:954. [PMID: 32528472 DOI: 10.3389/fimmu.2020.00954] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Quaglia M, Merlotti G, Guglielmetti G, Castellano G, Cantaluppi V. Recent Advances on Biomarkers of Early and Late Kidney Graft Dysfunction. Int J Mol Sci 2020;21:E5404. [PMID: 32751357 DOI: 10.3390/ijms21155404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
4 Deen CPJ, Veen AV, Gomes-Neto AW, Geleijnse JM, Berg KJBD, Heiner-Fokkema MR, Kema IP, Bakker SJL. Urinary Excretion of N1-Methylnicotinamide and N1-Methyl-2-Pyridone-5-Carboxamide and Mortality in Kidney Transplant Recipients. Nutrients 2020;12:E2059. [PMID: 32664445 DOI: 10.3390/nu12072059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Korytowska N, Wyczałkowska-Tomasik A, Pączek L, Giebułtowicz J. Evaluation of Salivary Indoxyl Sulfate with Proteinuria for Predicting Graft Deterioration in Kidney Transplant Recipients. Toxins (Basel) 2021;13:571. [PMID: 34437442 DOI: 10.3390/toxins13080571] [Reference Citation Analysis]
6 Losappio V, Infante B, Leo S, Troise D, Calvaruso M, Vitale P, Renzi S, Stallone G, Castellano G. Nutrition-Based Management of Inflammaging in CKD and Renal Replacement Therapies. Nutrients 2021;13:267. [PMID: 33477671 DOI: 10.3390/nu13010267] [Reference Citation Analysis]
7 Hernández D, Vázquez T, Alonso-Titos J, León M, Caballero A, Cobo MA, Sola E, López V, Ruiz-Esteban P, Cruzado JM, Sellarés J, Moreso F, Manonelles A, Torio A, Cabello M, Delgado-Burgos J, Casas C, Gutiérrez E, Jironda C, Kanter J, Serón D, Torres A. Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant Recipients. J Clin Med 2021;10:1934. [PMID: 33947168 DOI: 10.3390/jcm10091934] [Reference Citation Analysis]
8 Banas MC, Böhmig GA, Viklicky O, Rostaing LP, Jouve T, Guirado L, Facundo C, Bestard O, Gröne HJ, Kobayashi K, Hanzal V, Putz FJ, Zecher D, Bergler T, Neumann S, Rothe V, Schwäble Santamaria AG, Schiffer E, Banas B. A Prospective Multicenter Trial to Evaluate Urinary Metabolomics for Non-invasive Detection of Renal Allograft Rejection (PARASOL): Study Protocol and Patient Recruitment. Front Med (Lausanne) 2021;8:780585. [PMID: 35071266 DOI: 10.3389/fmed.2021.780585] [Reference Citation Analysis]
9 Angelico R, Pellicciaro M, Venza F, Manzia T, Cacciola R, Anselmo A, Toti L, Monaco A, Iaria G, Tisone G. Urological Complications in Kidney Transplant Recipients: Analysis of the Risk Factors and Impact on Transplant Outcomes in the Era of “Extended Criteria Donors”. Transplantology 2021;2:22-36. [DOI: 10.3390/transplantology2010003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Palmisano A, Gandolfini I, Delsante M, Cantarelli C, Fiaccadori E, Cravedi P, Maggiore U. Acute Kidney Injury (AKI) before and after Kidney Transplantation: Causes, Medical Approach, and Implications for the Long-Term Outcomes. J Clin Med 2021;10:1484. [PMID: 33918444 DOI: 10.3390/jcm10071484] [Reference Citation Analysis]
11 Echterdiek F, Latus J, Döhler B, Schwenger V, Süsal C. Impact of HLA compatibility in recipients of kidneys from expanded criteria donors: A Collaborative Transplant Study Report. Int J Immunogenet 2021;48:201-10. [PMID: 32945128 DOI: 10.1111/iji.12512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Franzin R, Stasi A, Fiorentino M, Simone S, Oberbauer R, Castellano G, Gesualdo L. Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials. Front Immunol 2021;12:673562. [PMID: 34295329 DOI: 10.3389/fimmu.2021.673562] [Reference Citation Analysis]
13 Maanaoui M, Provôt F, Hazzan M. [Very-old deceased donors in kidney transplantation: How far can we go?]. Nephrol Ther 2020;16:408-13. [PMID: 33203614 DOI: 10.1016/j.nephro.2020.06.002] [Reference Citation Analysis]